Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Qiagen (QGEN) over the last 12 years, with Q4 2025 value amounting to $839.0 million.

  • Qiagen's Cash & Equivalents rose 2644.09% to $839.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $839.0 million, marking a year-over-year increase of 2644.09%. This contributed to the annual value of $839.0 million for FY2025, which is 2644.09% up from last year.
  • According to the latest figures from Q4 2025, Qiagen's Cash & Equivalents is $839.0 million, which was up 2644.09% from $1.4 billion recorded in Q3 2025.
  • In the past 5 years, Qiagen's Cash & Equivalents ranged from a high of $1.4 billion in Q3 2025 and a low of $359.2 million during Q1 2023
  • In the last 5 years, Qiagen's Cash & Equivalents had a median value of $706.5 million in 2022 and averaged $747.6 million.
  • Per our database at Business Quant, Qiagen's Cash & Equivalents skyrocketed by 10591.3% in 2022 and then tumbled by 5439.32% in 2023.
  • Quarter analysis of 5 years shows Qiagen's Cash & Equivalents stood at $879.9 million in 2021, then fell by 16.96% to $730.7 million in 2022, then dropped by 8.57% to $668.1 million in 2023, then decreased by 0.68% to $663.6 million in 2024, then rose by 26.44% to $839.0 million in 2025.
  • Its last three reported values are $839.0 million in Q4 2025, $1.4 billion for Q3 2025, and $733.8 million during Q2 2025.